Implantica AG (OSTO:IMP A SDB) Operating Cash Flow per Share : kr (TTM As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Operating Cash Flow per Share?

Implantica AG's operating cash flow per share for the six months ended in . 20 was kr0.00. Implantica AG does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Implantica AG's Operating Cash Flow per Share or its related term are showing as below:

OSTO:IMP A SDB's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 8.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Implantica AG Operating Cash Flow per Share Historical Data

The historical data trend for Implantica AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Operating Cash Flow per Share Chart

Implantica AG Annual Data

Trend

Operating Cash Flow per Share

Implantica AG Semi-Annual Data

Operating Cash Flow per Share

Competitive Comparison of Implantica AG's Operating Cash Flow per Share

For the Medical Devices subindustry, Implantica AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Implantica AG's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Implantica AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Implantica AG's Operating Cash Flow per Share for the fiscal year that ended in . 20 is calculated as

Operating Cash Flow per Share (A: . 20 )	=	Cash Flow from Operations (A: . 20 )	/	Shares Outstanding (Diluted Average) (A: . 20 )
	=		/	0
	=

Implantica AG's Operating Cash Flow per Share for the quarter that ended in . 20 is calculated as

Operating Cash Flow per Share (Q: . 20 )	=	Cash Flow from Operations (Q: . 20 )	/	Shares Outstanding (Diluted Average) (Q: . 20 )
	=		/	0
	=

Implantica AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Implantica AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

8IM1:Germany

Address

Aeulestrasse 45, Vaduz, LIE, 9490

Website

https://www.implantica.com

Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines